Does Fermatron plus improve pain and functioning in patients with knee OA compared to placebo?

Phase 3

Completed

• Conditions: degenerative joint disease; Osteoarthritis; 10023213

• Registration Number: NL-OMON31817
• Lead Sponsor: Sint Annaziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

Mild osteoarthritis of the knee, Kellgren-Lawrence grade I-III

Exclusion Criteria

Bilateral osteoarthritis of the knee
Pregnancy
Lactation
Infection of the knee
evidence of skin disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>1. Pain in the affected knee<br /><br>2. Restricions in daily activities due to the affected knee</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1. Patient satisfaction with the applied treatment<br /><br>2. Safety of the applied treatment.<br /><br>3. Range of motion in the affected knee</p><br>